Newsletter Archive
-
03.28.23 -- Trends In FDA FY2022 Inspection-based Warning Letters
3/28/2023
03/28/23 Laboratory Network Newsletter
-
03.14.23 -- Considerations For Microbial Enumeration Methods When Working With CDMOs
3/14/2023
03/14/23 Laboratory Network Newsletter
-
02.28.23 -- FDA Adopts ICH Final Guidance On Bioanalytical Method Validation
2/28/2023
02/28/23 Laboratory Network Newsletter
-
02.14.23 -- Considerations For Sterility Test Methods When Working With CDMOs
2/14/2023
02/14/23 Laboratory Network Newsletter
-
01.24.23 -- FDA Seeks Comment On Circumstances For Delaying, Denying, Limiting, Or Refusing An Inspection
1/24/2023
01/24/23 Laboratory Network Newsletter
-
01.10.23 -- ICH Issues Draft Guideline On Viral Safety Evaluation Of Biotech Products
1/10/2023
01/10/23 Laboratory Network Newsletter
-
12.20.22 -- How Can Nanomedicine Innovations Combat Cancer?
12/20/2022
12/20/22 Laboratory Network Newsletter
-
12.06.22 -- Digital Twins & The CGT Value Chain: A Universe Of Possibilities
12/6/2022
12/06/22 Laboratory Network Newsletter
-
11.22.22 -- Pharma 4.0 Software Methodologies In Biopharma & Medical Devices
11/22/2022
11/22/22 Laboratory Network Newsletter
-
11.08.22 -- 6 Drug Discovery Learnings From The Lab
11/8/2022
11/08/22 Laboratory Network Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more